Discover QuantumOmix™
Precision Medicine Through Multi-Omics AI
Precision Medicine Through Multi-Omics AI
Precision Medicine Through Multi-Omics AI
Precision Medicine Through Multi-Omics AI
QuantumOmix™ integrates genomics, transcriptomics, proteomics, and metabolomics data using quantum-inspired algorithms to reveal hidden disease mechanisms and personalized treatment pathways.
QuantumOmix™ integrates genomics, transcriptomics, proteomics, and metabolomics data using quantum-inspired algorithms to reveal hidden disease mechanisms and personalized treatment pathways.
QuantumOmix™ integrates genomics, transcriptomics, proteomics, and metabolomics data using quantum-inspired algorithms to reveal hidden disease mechanisms and personalized treatment pathways.
QuantumOmix™
Transform fragmented biological data into unified disease insights
QuantumOmix™
Transform fragmented biological data into unified disease insights
QuantumOmix™
Transform fragmented biological data into unified disease insights
QuantumOmix™
Transform fragmented biological data into unified disease insights
The Challenge
The Critical Problem in Biological Data Analysis
Single-omics approaches leave critical insights undiscovered
Fragmented Data Silos
Isolated analysis of genomics, proteomics, and metabolomics misses critical interactions and obscures disease complexity.
Fragmented Data Silos
Isolated analysis of genomics, proteomics, and metabolomics misses critical interactions and obscures disease complexity.
Fragmented Data Silos
Isolated analysis of genomics, proteomics, and metabolomics misses critical interactions and obscures disease complexity.
Fragmented Data Silos
Isolated analysis of genomics, proteomics, and metabolomics misses critical interactions and obscures disease complexity.
Missed Pattern Recognition
Conventional methods fail to identify subtle patterns across omics datasets, overlooking novel biomarkers and targets.
Missed Pattern Recognition
Conventional methods fail to identify subtle patterns across omics datasets, overlooking novel biomarkers and targets.
Missed Pattern Recognition
Conventional methods fail to identify subtle patterns across omics datasets, overlooking novel biomarkers and targets.
Missed Pattern Recognition
Conventional methods fail to identify subtle patterns across omics datasets, overlooking novel biomarkers and targets.
Incomplete Disease Understanding
Single-omics studies miss biological networks driving disease, leading to treatments targeting isolated pathways.
Incomplete Disease Understanding
Single-omics studies miss biological networks driving disease, leading to treatments targeting isolated pathways.
Incomplete Disease Understanding
Single-omics studies miss biological networks driving disease, leading to treatments targeting isolated pathways.
Incomplete Disease Understanding
Single-omics studies miss biological networks driving disease, leading to treatments targeting isolated pathways.
Limited Personalization
Current approaches cannot correlate individual omics profiles with outcomes, preventing precision medicine.
Limited Personalization
Current approaches cannot correlate individual omics profiles with outcomes, preventing precision medicine.
Limited Personalization
Current approaches cannot correlate individual omics profiles with outcomes, preventing precision medicine.
Limited Personalization
Current approaches cannot correlate individual omics profiles with outcomes, preventing precision medicine.
Our Solution
AI-Powered Multi-Omics
QuantumOmix™ provides comprehensive integration capabilities that unlock biological complexity
5+ Omics Layer Integration
Combine genomics, transcriptomics, proteomics, metabolomics, and epigenomics into unified biological profiles with automated quality control.
5+ Omics Layer Integration
Combine genomics, transcriptomics, proteomics, metabolomics, and epigenomics into unified biological profiles with automated quality control.
5+ Omics Layer Integration
Combine genomics, transcriptomics, proteomics, metabolomics, and epigenomics into unified biological profiles with automated quality control.
5+ Omics Layer Integration
Combine genomics, transcriptomics, proteomics, metabolomics, and epigenomics into unified biological profiles with automated quality control.
Quantum Pattern Recognition
Advanced algorithms identify complex correlations across high-dimensional datasets, discovering biomarkers and targets missed by conventional analysis.
Quantum Pattern Recognition
Advanced algorithms identify complex correlations across high-dimensional datasets, discovering biomarkers and targets missed by conventional analysis.
Quantum Pattern Recognition
Advanced algorithms identify complex correlations across high-dimensional datasets, discovering biomarkers and targets missed by conventional analysis.
Quantum Pattern Recognition
Advanced algorithms identify complex correlations across high-dimensional datasets, discovering biomarkers and targets missed by conventional analysis.
Pathway Network Mapping
Comprehensive biological pathway analysis reveals disease mechanisms and pinpoints optimal intervention points for drug development.
Pathway Network Mapping
Comprehensive biological pathway analysis reveals disease mechanisms and pinpoints optimal intervention points for drug development.
Pathway Network Mapping
Comprehensive biological pathway analysis reveals disease mechanisms and pinpoints optimal intervention points for drug development.
Pathway Network Mapping
Comprehensive biological pathway analysis reveals disease mechanisms and pinpoints optimal intervention points for drug development.
AI Biomarker Discovery
Machine learning models identify multi-omics signatures that outperform single-layer biomarkers for disease diagnosis and treatment prediction.
AI Biomarker Discovery
Machine learning models identify multi-omics signatures that outperform single-layer biomarkers for disease diagnosis and treatment prediction.
AI Biomarker Discovery
Machine learning models identify multi-omics signatures that outperform single-layer biomarkers for disease diagnosis and treatment prediction.
AI Biomarker Discovery
Machine learning models identify multi-omics signatures that outperform single-layer biomarkers for disease diagnosis and treatment prediction.
Platform Capabilities
Advanced Platform Capabilities
Advanced Platform Capabilities
Advanced Platform Capabilities
Advanced Platform Capabilities
QuantumOmix™ offers Enterprise-grade features for sophisticated biological analysis
QuantumOmix™ offers Enterprise-grade features for sophisticated biological analysis
Systems Biology Modeling
Improved disease models integrating multiple omics layers, identify therapeutic intervention strategy
Systems Biology Modeling
Improved disease models integrating multiple omics layers, identify therapeutic intervention strategy
Systems Biology Modeling
Improved disease models integrating multiple omics layers, identify therapeutic intervention strategy
Systems Biology Modeling
Improved disease models integrating multiple omics layers, identify therapeutic intervention strategy
Real-Time Processing
Process terabytes of multi-omics data in hours rather than weeks, accelerating discovery timelines.
Real-Time Processing
Process terabytes of multi-omics data in hours rather than weeks, accelerating discovery timelines.
Real-Time Processing
Process terabytes of multi-omics data in hours rather than weeks, accelerating discovery timelines.
Real-Time Processing
Process terabytes of multi-omics data in hours rather than weeks, accelerating discovery timelines.
Cohort Analysis
Analyze population-scale datasets to identify disease subtypes and discover biomarkers across diverse populations.
Cohort Analysis
Analyze population-scale datasets to identify disease subtypes and discover biomarkers across diverse populations.
Cohort Analysis
Analyze population-scale datasets to identify disease subtypes and discover biomarkers across diverse populations.
Cohort Analysis
Analyze population-scale datasets to identify disease subtypes and discover biomarkers across diverse populations.
Clinical Integration
Seamless integration with clinical trial data and EHRs to correlate omics profiles with patient outcomes.
Clinical Integration
Seamless integration with clinical trial data and EHRs to correlate omics profiles with patient outcomes.
Clinical Integration
Seamless integration with clinical trial data and EHRs to correlate omics profiles with patient outcomes.
Clinical Integration
Seamless integration with clinical trial data and EHRs to correlate omics profiles with patient outcomes.
Automated Reporting
Generate publication-ready reports with statistical validation and biological interpretation for submissions.
Automated Reporting
Generate publication-ready reports with statistical validation and biological interpretation for submissions.
Automated Reporting
Generate publication-ready reports with statistical validation and biological interpretation for submissions.
Automated Reporting
Generate publication-ready reports with statistical validation and biological interpretation for submissions.
Collaborative Workspace
Cloud-based platform enables secure data sharing across research teams, institutions, and partnerships.
Collaborative Workspace
Cloud-based platform enables secure data sharing across research teams, institutions, and partnerships.
Collaborative Workspace
Cloud-based platform enables secure data sharing across research teams, institutions, and partnerships.
Collaborative Workspace
Cloud-based platform enables secure data sharing across research teams, institutions, and partnerships.
Technology
Proprietary Technology Stack
Proprietary
Technology Stack
Proprietary
Technology Stack
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Python Ecosystem
Python Ecosystem
Python Ecosystem
Python Ecosystem
TensorFlow/PyTorch
TensorFlow/PyTorch
TensorFlow/PyTorch
TensorFlow/PyTorch
Advanced CNNs
Advanced CNNs
Advanced CNNs
Advanced CNNs
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
Cloud Native
Cloud Native
Cloud Native
Cloud Native
Multi-Platform
Multi-Platform
Multi-Platform
Multi-Platform
Our Difference
QuantumOmix™ vs The World
Quantumvision™
vs the world
Quantumvision™
vs the world
QuantumOmix™ vs The World
See how integrated multi-omics analysis outperforms traditional approaches
Built on cutting-edge AI research with robust, secure,
and scalable clinical-grade infrastructure.
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
See how integrated multi-omics analysis outperforms traditional approaches
Current Methods
Current Methods
Current Methods
QuantumOmix™
Multi-Omics Integration
Combine genomics, proteomics, metabolomics
Manual/Siloed analysis
Manual
/
Siloed analysis
Manual
/
Siloed analysis
Seamless automated integration
Pattern Recognition
Identify correlations across biological layers
Limited to single layerstly variable
High-dimensional cross-layer
High-dimensional
cross-layer
Biomarker Discovery
Novel predictive biomarker identification
Single-omics candidates
Multi-layer validated markers
Pathway Analysis
Disease mechanism elucidation
Basic pathway mapping
Comprehensive network analysis
Drug Target Identification
Therapeutic target discovery
Limited hypothesis-based
Systematic data-driven
Data Processing Time
Complex dataset analysis completion
Weeks to months
Days
Personalized Medicine Insights
Individual treatment prediction
Population-based approaches
Individual omics profiling
Scalability
Handle large cohort studies
Limited by infrastructure
Massively parallel processing
Research Productivity
Discovery throughput and efficiency
Standard
Significantly accelerated
Our people
Leadership Team
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Our people
Leadership Team
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
Our people
Leadership
Team
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
Market Opportunity
Massive Market Opportunity
Massive
Market Opportunity
Massive
Market Opportunity
Massive Market Opportunity
Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.
Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Technology
Proprietary Technology Stack
Proprietary
Technology Stack
Proprietary
Technology Stack
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.